SGMOQ 8-K 2026-07-20

SANGAMO THERAPEUTICS, INC (SGMOQ) 8-K dated 2026-07-20 — accession 0001193125-26-309012. This URL is the filing, not the SGMOQ hub.

SANGAMO THERAPEUTICS, INC (SGMOQ) common stock.

SANGAMO THERAPEUTICS, INC filed a 8-K on 2026-07-20. Accession 0001193125-26-309012.

Cached items: 1.03, 3.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported SGMOQ revenue for 2025-12-31 was $39.6M. Net income was -$122.9M. Revenue was down 31.6% from 2024-12-31 to 2025-12-31.

Not investment advice. The SGMOQ SEC hub lists recent forms. The stock page is the research view.